Diffusion Weighted MRI for Hepatic Fibrosis: Impact of b-Value

AuthorHuseyin Ozkurten
AuthorFirat Keskineren
AuthorOzan Karatagen
AuthorCanan Alkimen
AuthorSukru Mehmet Erturken
AuthorMuzaffer Basaken
AuthorHuseyin Ozkurten
Issued Date2014-01-31en
AbstractHepatic fibrosis is a typical complication of chronic liver diseases resulting in cirrhosis that remains a major public health problem worldwide. Liver biopsy is currently the gold standard for diagnosing and staging hepatic fibrosis. Percutaneous liver biopsy; however, is an invasive procedure with risks of complications. Therefore, there is need for alternative non-invasive techniques to assess liver fibrosis and chronic liver diseases. In recent years, MRI techniques, including diffusion weighted imaging (DWI), have been developed for in vivo quantification of liver fibrosis.en
DOIhttps://doi.org/10.5812/iranjradiol.3555en
KeywordLiver Cirrhosisen
KeywordMagnetic Resonance Imagingen
KeywordDiffusion Magnetic Resonance Imagingen
PublisherBrieflandsen
TitleDiffusion Weighted MRI for Hepatic Fibrosis: Impact of b-Valueen
TypeResearch Articleen

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
75109-pdf.pdf
Size:
650.38 KB
Format:
Adobe Portable Document Format
Description:
Article/s PDF

Collections